APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plaque Psoriasis Treatment Medications

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Plaque Psoriasis Treatment Medications Market Outlook and Growth Opportunities 2026

29 December 2025202 pages

Choose your research edition.

Industry ResearchPlaque Psoriasis Treatment Medications Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Plaque Psoriasis Treatment Medications Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Plaque Psoriasis Treatment Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plaque Psoriasis Treatment Medications Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Plaque Psoriasis Treatment Medications Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Plaque Psoriasis Treatment Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plaque Psoriasis Treatment Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plaque Psoriasis Treatment Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plaque Psoriasis Treatment Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plaque Psoriasis Treatment Medications market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plaque Psoriasis Treatment Medications market include Johnson & Johnson, Novartis, Merck, Eli Lilly, Pfizer, UCB, Organon, LEO Pharma and Galectin Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Plaque Psoriasis Treatment Medications market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plaque Psoriasis Treatment Medications and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plaque Psoriasis Treatment Medications sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plaque Psoriasis Treatment Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Plaque Psoriasis Treatment Medications Segment by Company

Johnson & Johnson

Novartis

Merck

Eli Lilly

Pfizer

UCB

Organon

LEO Pharma

Galectin Therapeutics

Dermira

Cellceutix

Biogen

Bayer

AstraZeneca

Amgen

Allergan

AbbVie

Plaque Psoriasis Treatment Medications Segment by Type

Non-biologic Drugs

Biologics

Small Molecule Drugs

Plaque Psoriasis Treatment Medications Segment by Application

Hospital

Clinic

Other

Plaque Psoriasis Treatment Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Plaque Psoriasis Treatment Medications status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Plaque Psoriasis Treatment Medications market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plaque Psoriasis Treatment Medications significant trends, drivers, influence factors in global and regions.

6. To analyze Plaque Psoriasis Treatment Medications competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plaque Psoriasis Treatment Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plaque Psoriasis Treatment Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plaque Psoriasis Treatment Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plaque Psoriasis Treatment Medications market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plaque Psoriasis Treatment Medications industry.

Chapter 3: Detailed analysis of Plaque Psoriasis Treatment Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Plaque Psoriasis Treatment Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Plaque Psoriasis Treatment Medications in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plaque Psoriasis Treatment Medications Industry Trends Table 2. Plaque Psoriasis Treatment Medications Industry Drivers Table 3. Plaque Psoriasis Treatment Medications Industry Opportunities and Challenges Table 4. Plaque Psoriasis Treatment Medications Industry Restraints Table 5. Global Plaque Psoriasis Treatment Medications Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plaque Psoriasis Treatment Medications Revenue Share by Company (2021-2026) Table 7. Global Plaque Psoriasis Treatment Medications Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Plaque Psoriasis Treatment Medications Sales Volume Share by Company (2021-2026) Table 9. Global Plaque Psoriasis Treatment Medications Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Plaque Psoriasis Treatment Medications Company Ranking, (2024-2026) & (USD Million) Table 11. Global Plaque Psoriasis Treatment Medications Key Company Manufacturing Base & Headquarters Table 12. Global Plaque Psoriasis Treatment Medications Company, Product Type & Application Table 13. Global Plaque Psoriasis Treatment Medications Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Plaque Psoriasis Treatment Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Non-biologic Drugs Table 18. Significant Companies of Biologics Table 19. Significant Companies of Small Molecule Drugs Table 20. Global Plaque Psoriasis Treatment Medications Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Plaque Psoriasis Treatment Medications Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Plaque Psoriasis Treatment Medications Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Plaque Psoriasis Treatment Medications Sales Volume Share by Type (2021-2026) Table 24. Global Plaque Psoriasis Treatment Medications Sales Volume Share by Type (2027-2032) Table 25. Global Plaque Psoriasis Treatment Medications Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Plaque Psoriasis Treatment Medications Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Plaque Psoriasis Treatment Medications Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Plaque Psoriasis Treatment Medications Sales Value Share by Type (2021-2026) Table 29. Global Plaque Psoriasis Treatment Medications Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Plaque Psoriasis Treatment Medications Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Plaque Psoriasis Treatment Medications Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Plaque Psoriasis Treatment Medications Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Plaque Psoriasis Treatment Medications Sales Volume Share by Application (2021-2026) Table 37. Global Plaque Psoriasis Treatment Medications Sales Volume Share by Application (2027-2032) Table 38. Global Plaque Psoriasis Treatment Medications Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Plaque Psoriasis Treatment Medications Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Plaque Psoriasis Treatment Medications Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Plaque Psoriasis Treatment Medications Sales Value Share by Application (2021-2026) Table 42. Global Plaque Psoriasis Treatment Medications Sales Value Share by Application (2027-2032) Table 43. Global Plaque Psoriasis Treatment Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Plaque Psoriasis Treatment Medications Sales by Region (2021-2026) & (K Units) Table 45. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2021-2026) Table 46. Global Plaque Psoriasis Treatment Medications Sales by Region (2027-2032) & (K Units) Table 47. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2027-2032) Table 48. Global Plaque Psoriasis Treatment Medications Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Plaque Psoriasis Treatment Medications Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Plaque Psoriasis Treatment Medications Sales Value Share by Region (2021-2026) Table 51. Global Plaque Psoriasis Treatment Medications Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Plaque Psoriasis Treatment Medications Sales Value Share by Region (2027-2032) Table 53. Global Plaque Psoriasis Treatment Medications Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Plaque Psoriasis Treatment Medications Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Plaque Psoriasis Treatment Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Plaque Psoriasis Treatment Medications Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 58. Global Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021-2026) Table 59. Global Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 60. Global Plaque Psoriasis Treatment Medications Sales Market Share by Country (2027-2032) Table 61. Global Plaque Psoriasis Treatment Medications Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Plaque Psoriasis Treatment Medications Sales Value Market Share by Country (2021-2026) Table 63. Global Plaque Psoriasis Treatment Medications Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Plaque Psoriasis Treatment Medications Sales Value Market Share by Country (2027-2032) Table 65. Johnson & Johnson Company Information Table 66. Johnson & Johnson Business Overview Table 67. Johnson & Johnson Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Johnson & Johnson Plaque Psoriasis Treatment Medications Product Portfolio Table 69. Johnson & Johnson Recent Development Table 70. Novartis Company Information Table 71. Novartis Business Overview Table 72. Novartis Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Novartis Plaque Psoriasis Treatment Medications Product Portfolio Table 74. Novartis Recent Development Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Merck Plaque Psoriasis Treatment Medications Product Portfolio Table 79. Merck Recent Development Table 80. Eli Lilly Company Information Table 81. Eli Lilly Business Overview Table 82. Eli Lilly Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Eli Lilly Plaque Psoriasis Treatment Medications Product Portfolio Table 84. Eli Lilly Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pfizer Plaque Psoriasis Treatment Medications Product Portfolio Table 89. Pfizer Recent Development Table 90. UCB Company Information Table 91. UCB Business Overview Table 92. UCB Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. UCB Plaque Psoriasis Treatment Medications Product Portfolio Table 94. UCB Recent Development Table 95. Organon Company Information Table 96. Organon Business Overview Table 97. Organon Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Organon Plaque Psoriasis Treatment Medications Product Portfolio Table 99. Organon Recent Development Table 100. LEO Pharma Company Information Table 101. LEO Pharma Business Overview Table 102. LEO Pharma Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. LEO Pharma Plaque Psoriasis Treatment Medications Product Portfolio Table 104. LEO Pharma Recent Development Table 105. Galectin Therapeutics Company Information Table 106. Galectin Therapeutics Business Overview Table 107. Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Portfolio Table 109. Galectin Therapeutics Recent Development Table 110. Dermira Company Information Table 111. Dermira Business Overview Table 112. Dermira Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Dermira Plaque Psoriasis Treatment Medications Product Portfolio Table 114. Dermira Recent Development Table 115. Cellceutix Company Information Table 116. Cellceutix Business Overview Table 117. Cellceutix Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Cellceutix Plaque Psoriasis Treatment Medications Product Portfolio Table 119. Cellceutix Recent Development Table 120. Biogen Company Information Table 121. Biogen Business Overview Table 122. Biogen Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Biogen Plaque Psoriasis Treatment Medications Product Portfolio Table 124. Biogen Recent Development Table 125. Bayer Company Information Table 126. Bayer Business Overview Table 127. Bayer Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Bayer Plaque Psoriasis Treatment Medications Product Portfolio Table 129. Bayer Recent Development Table 130. AstraZeneca Company Information Table 131. AstraZeneca Business Overview Table 132. AstraZeneca Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. AstraZeneca Plaque Psoriasis Treatment Medications Product Portfolio Table 134. AstraZeneca Recent Development Table 135. Amgen Company Information Table 136. Amgen Business Overview Table 137. Amgen Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Amgen Plaque Psoriasis Treatment Medications Product Portfolio Table 139. Amgen Recent Development Table 140. Allergan Company Information Table 141. Allergan Business Overview Table 142. Allergan Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Allergan Plaque Psoriasis Treatment Medications Product Portfolio Table 144. Allergan Recent Development Table 145. AbbVie Company Information Table 146. AbbVie Business Overview Table 147. AbbVie Plaque Psoriasis Treatment Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. AbbVie Plaque Psoriasis Treatment Medications Product Portfolio Table 149. AbbVie Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Plaque Psoriasis Treatment Medications Distributors List Table 153. Plaque Psoriasis Treatment Medications Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Plaque Psoriasis Treatment Medications Product Image Figure 2. Global Plaque Psoriasis Treatment Medications Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plaque Psoriasis Treatment Medications Sales Value (2021-2032) & (US$ Million) Figure 4. Global Plaque Psoriasis Treatment Medications Sales (2021-2032) & (K Units) Figure 5. Global Plaque Psoriasis Treatment Medications Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Plaque Psoriasis Treatment Medications Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Non-biologic Drugs Image Figure 10. Biologics Image Figure 11. Small Molecule Drugs Image Figure 12. Global Plaque Psoriasis Treatment Medications Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Plaque Psoriasis Treatment Medications Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Plaque Psoriasis Treatment Medications Sales Volume Share by Type (2021-2032) Figure 15. Global Plaque Psoriasis Treatment Medications Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Plaque Psoriasis Treatment Medications Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Plaque Psoriasis Treatment Medications Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Plaque Psoriasis Treatment Medications Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Plaque Psoriasis Treatment Medications Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Plaque Psoriasis Treatment Medications Sales Volume Share by Application (2021-2032) Figure 24. Global Plaque Psoriasis Treatment Medications Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Plaque Psoriasis Treatment Medications Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Plaque Psoriasis Treatment Medications Sales Value Share by Application (2021-2032) Figure 27. Global Plaque Psoriasis Treatment Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Plaque Psoriasis Treatment Medications Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Plaque Psoriasis Treatment Medications Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Plaque Psoriasis Treatment Medications Sales Value (2021-2032) & (US$ Million) Figure 32. North America Plaque Psoriasis Treatment Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Plaque Psoriasis Treatment Medications Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Plaque Psoriasis Treatment Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Plaque Psoriasis Treatment Medications Sales Value (2021-2032) & (US$ Million) Figure 38. South America Plaque Psoriasis Treatment Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Plaque Psoriasis Treatment Medications Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Plaque Psoriasis Treatment Medications Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Non-biologic Drugs
  • Biologics
  • Small Molecule Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • UCB
  • Organon
  • LEO Pharma
  • Galectin Therapeutics
  • Dermira
  • Cellceutix
  • Biogen
  • Bayer
  • AstraZeneca
  • Amgen
  • Allergan
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plaque Psoriasis Treatment Medications Sales Value (2021-2032)
  4. 1.2.2 Global Plaque Psoriasis Treatment Medications Sales Volume (2021-2032)
  5. 1.2.3 Global Plaque Psoriasis Treatment Medications Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Plaque Psoriasis Treatment Medications Market Dynamics
  1. 2.1 Plaque Psoriasis Treatment Medications Industry Trends
  2. 2.2 Plaque Psoriasis Treatment Medications Industry Drivers
  3. 2.3 Plaque Psoriasis Treatment Medications Industry Opportunities and Challenges
  4. 2.4 Plaque Psoriasis Treatment Medications Industry Restraints
3 Plaque Psoriasis Treatment Medications Market by Company
  1. 3.1 Global Plaque Psoriasis Treatment Medications Company Revenue Ranking in 2025
  2. 3.2 Global Plaque Psoriasis Treatment Medications Revenue by Company (2021-2026)
  3. 3.3 Global Plaque Psoriasis Treatment Medications Sales Volume by Company (2021-2026)
  4. 3.4 Global Plaque Psoriasis Treatment Medications Average Price by Company (2021-2026)
  5. 3.5 Global Plaque Psoriasis Treatment Medications Company Ranking (2024-2026)
  6. 3.6 Global Plaque Psoriasis Treatment Medications Company Manufacturing Base and Headquarters
  7. 3.7 Global Plaque Psoriasis Treatment Medications Company Product Type and Application
  8. 3.8 Global Plaque Psoriasis Treatment Medications Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Plaque Psoriasis Treatment Medications Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Plaque Psoriasis Treatment Medications Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Plaque Psoriasis Treatment Medications Market by Type
  1. 4.1 Plaque Psoriasis Treatment Medications Type Introduction
  2. 4.1.1 Non-biologic Drugs
  3. 4.1.2 Biologics
  4. 4.1.3 Small Molecule Drugs
  5. 4.2 Global Plaque Psoriasis Treatment Medications Sales Volume by Type
  6. 4.2.1 Global Plaque Psoriasis Treatment Medications Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Plaque Psoriasis Treatment Medications Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Plaque Psoriasis Treatment Medications Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Plaque Psoriasis Treatment Medications Sales Value by Type
  10. 4.3.1 Global Plaque Psoriasis Treatment Medications Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Plaque Psoriasis Treatment Medications Sales Value by Type (2021-2032)
  12. 4.3.3 Global Plaque Psoriasis Treatment Medications Sales Value Share by Type (2021-2032)
5 Plaque Psoriasis Treatment Medications Market by Application
  1. 5.1 Plaque Psoriasis Treatment Medications Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Plaque Psoriasis Treatment Medications Sales Volume by Application
  6. 5.2.1 Global Plaque Psoriasis Treatment Medications Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plaque Psoriasis Treatment Medications Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Plaque Psoriasis Treatment Medications Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Plaque Psoriasis Treatment Medications Sales Value by Application
  10. 5.3.1 Global Plaque Psoriasis Treatment Medications Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Plaque Psoriasis Treatment Medications Sales Value by Application (2021-2032)
  12. 5.3.3 Global Plaque Psoriasis Treatment Medications Sales Value Share by Application (2021-2032)
6 Plaque Psoriasis Treatment Medications Regional Sales and Value Analysis
  1. 6.1 Global Plaque Psoriasis Treatment Medications Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plaque Psoriasis Treatment Medications Sales by Region (2021-2032)
  3. 6.2.1 Global Plaque Psoriasis Treatment Medications Sales by Region: 2021-2026
  4. 6.2.2 Global Plaque Psoriasis Treatment Medications Sales by Region (2027-2032)
  5. 6.3 Global Plaque Psoriasis Treatment Medications Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Plaque Psoriasis Treatment Medications Sales Value by Region (2021-2032)
  7. 6.4.1 Global Plaque Psoriasis Treatment Medications Sales Value by Region: 2021-2026
  8. 6.4.2 Global Plaque Psoriasis Treatment Medications Sales Value by Region (2027-2032)
  9. 6.5 Global Plaque Psoriasis Treatment Medications Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Plaque Psoriasis Treatment Medications Sales Value (2021-2032)
  12. 6.6.2 North America Plaque Psoriasis Treatment Medications Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Plaque Psoriasis Treatment Medications Sales Value (2021-2032)
  15. 6.7.2 Europe Plaque Psoriasis Treatment Medications Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Plaque Psoriasis Treatment Medications Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Plaque Psoriasis Treatment Medications Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Plaque Psoriasis Treatment Medications Sales Value (2021-2032)
  21. 6.9.2 South America Plaque Psoriasis Treatment Medications Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Plaque Psoriasis Treatment Medications Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Plaque Psoriasis Treatment Medications Sales Value Share by Country, 2025 VS 2032
7 Plaque Psoriasis Treatment Medications Country-level Sales and Value Analysis
  1. 7.1 Global Plaque Psoriasis Treatment Medications Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plaque Psoriasis Treatment Medications Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Plaque Psoriasis Treatment Medications Sales by Country (2021-2032)
  4. 7.3.1 Global Plaque Psoriasis Treatment Medications Sales by Country (2021-2026)
  5. 7.3.2 Global Plaque Psoriasis Treatment Medications Sales by Country (2027-2032)
  6. 7.4 Global Plaque Psoriasis Treatment Medications Sales Value by Country (2021-2032)
  7. 7.4.1 Global Plaque Psoriasis Treatment Medications Sales Value by Country (2021-2026)
  8. 7.4.2 Global Plaque Psoriasis Treatment Medications Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Plaque Psoriasis Treatment Medications Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Plaque Psoriasis Treatment Medications Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Plaque Psoriasis Treatment Medications Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Plaque Psoriasis Treatment Medications Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Plaque Psoriasis Treatment Medications Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Eli Lilly
  20. 8.4.1 Eli Lilly Company Information
  21. 8.4.2 Eli Lilly Business Overview
  22. 8.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Product Portfolio
  24. 8.4.5 Eli Lilly Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Plaque Psoriasis Treatment Medications Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 UCB
  32. 8.6.1 UCB Company Information
  33. 8.6.2 UCB Business Overview
  34. 8.6.3 UCB Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 UCB Plaque Psoriasis Treatment Medications Product Portfolio
  36. 8.6.5 UCB Recent Developments
  37. 8.7 Organon
  38. 8.7.1 Organon Company Information
  39. 8.7.2 Organon Business Overview
  40. 8.7.3 Organon Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Organon Plaque Psoriasis Treatment Medications Product Portfolio
  42. 8.7.5 Organon Recent Developments
  43. 8.8 LEO Pharma
  44. 8.8.1 LEO Pharma Company Information
  45. 8.8.2 LEO Pharma Business Overview
  46. 8.8.3 LEO Pharma Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LEO Pharma Plaque Psoriasis Treatment Medications Product Portfolio
  48. 8.8.5 LEO Pharma Recent Developments
  49. 8.9 Galectin Therapeutics
  50. 8.9.1 Galectin Therapeutics Company Information
  51. 8.9.2 Galectin Therapeutics Business Overview
  52. 8.9.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Portfolio
  54. 8.9.5 Galectin Therapeutics Recent Developments
  55. 8.10 Dermira
  56. 8.10.1 Dermira Company Information
  57. 8.10.2 Dermira Business Overview
  58. 8.10.3 Dermira Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Dermira Plaque Psoriasis Treatment Medications Product Portfolio
  60. 8.10.5 Dermira Recent Developments
  61. 8.11 Cellceutix
  62. 8.11.1 Cellceutix Company Information
  63. 8.11.2 Cellceutix Business Overview
  64. 8.11.3 Cellceutix Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Cellceutix Plaque Psoriasis Treatment Medications Product Portfolio
  66. 8.11.5 Cellceutix Recent Developments
  67. 8.12 Biogen
  68. 8.12.1 Biogen Company Information
  69. 8.12.2 Biogen Business Overview
  70. 8.12.3 Biogen Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Biogen Plaque Psoriasis Treatment Medications Product Portfolio
  72. 8.12.5 Biogen Recent Developments
  73. 8.13 Bayer
  74. 8.13.1 Bayer Company Information
  75. 8.13.2 Bayer Business Overview
  76. 8.13.3 Bayer Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bayer Plaque Psoriasis Treatment Medications Product Portfolio
  78. 8.13.5 Bayer Recent Developments
  79. 8.14 AstraZeneca
  80. 8.14.1 AstraZeneca Company Information
  81. 8.14.2 AstraZeneca Business Overview
  82. 8.14.3 AstraZeneca Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 AstraZeneca Plaque Psoriasis Treatment Medications Product Portfolio
  84. 8.14.5 AstraZeneca Recent Developments
  85. 8.15 Amgen
  86. 8.15.1 Amgen Company Information
  87. 8.15.2 Amgen Business Overview
  88. 8.15.3 Amgen Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Amgen Plaque Psoriasis Treatment Medications Product Portfolio
  90. 8.15.5 Amgen Recent Developments
  91. 8.16 Allergan
  92. 8.16.1 Allergan Company Information
  93. 8.16.2 Allergan Business Overview
  94. 8.16.3 Allergan Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Allergan Plaque Psoriasis Treatment Medications Product Portfolio
  96. 8.16.5 Allergan Recent Developments
  97. 8.17 AbbVie
  98. 8.17.1 AbbVie Company Information
  99. 8.17.2 AbbVie Business Overview
  100. 8.17.3 AbbVie Plaque Psoriasis Treatment Medications Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 AbbVie Plaque Psoriasis Treatment Medications Product Portfolio
  102. 8.17.5 AbbVie Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Plaque Psoriasis Treatment Medications Value Chain Analysis
  2. 9.1.1 Plaque Psoriasis Treatment Medications Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Plaque Psoriasis Treatment Medications Sales Mode & Process
  6. 9.2 Plaque Psoriasis Treatment Medications Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Plaque Psoriasis Treatment Medications Distributors
  9. 9.2.3 Plaque Psoriasis Treatment Medications Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst